Torrent cleared for semaglutide launch in India, defeats Novo Nordisk's injunction bid
Torrent Pharmaceuticals has been cleared to launch its semaglutide product after an Indian court found no infringement of Novo Nordisk’s formulation patent. The Delhi High Court stressed claim scope limits, permitting...To view the full article, register now.
Already a subscriber? Click here to view full article